Session Details
[O5]Oral Presentation 5
Sat. Sep 26, 2026 10:45 AM - 11:35 AM JST
Sat. Sep 26, 2026 1:45 AM - 2:35 AM UTC
Sat. Sep 26, 2026 1:45 AM - 2:35 AM UTC
Room 5(3F Conference Room 302A)
Chair:Shigeru Suga, Kuniko Nakayama
[O5-01]ハイリスク者に対する肺炎球菌ワクチン啓発の課題：学会横断的肺炎球菌ワクチン啓発プロジェクトの中間報告
*Kazunori Oishi1, Kazuko Yamamoto2, Hideaki Nagai3, Shigeki Nakamura4, Takaya Maruyama5, Masafumi Seki6, Naoki Hasegawa7, Daisuke Kurai8, Hiroshi Mukae9, Yu Arakawa10, Junichiro Nishi11, Naruhiko Ishiwada12, Keiji Okinaka13 (1. Toyama Institute of Health, 2. University of the Ryukyus, 3. National Hospitl Organization Tokyo Hospital, 4. Tokyo Medical Uiversity, 5. Mie Prefectural Ichishi Hospital, 6. Saitama Medical University, 7. Yokohama Municipal Hospital, 8. Kyorin University School of Medicine, 9. Nagasaki University, 10. Kochi Medical School, 11. Kagoshima University, 12. Chiba University Medical Mycology Research Center, 13. National Cancer Center Hospital East)
[O5-02]新規肺炎球菌結合型ワクチンにカバーされる成人の侵襲性肺炎球菌感染症罹患率及び予防可能な症例数の評価
*Kosuke Tamura Tamura1,4, Reiko Shimbashi2,4, Bin Chang3,4, Kenji Gotoh4, Yoshinari Tanabe4, Koji Kuronuma4, Kengo Oshima4, Takaya Maruyama4, Shuichi Abe4, Kei Kasahara4, Masashi Nakamatsu4, Junichiro Nishi4, Yu Arakawa4, Yukihiro Akeda3,4, Kazunori Oishi1,4 (1. Toyama Institute of Health, 2. Department of Infectious Disease Surveillance, National Institute of Infectious Diseases, Japan Institute for Health Security, 3. Department of Bacteriology I, National Institute of Infectious Diseases, Japan Institute for Health Security, 4. Adult IPD Study Group)
[O5-03]2019–2025年の成人肺炎球菌性肺炎における血清型分布と重症度との関連：J-PAVE2
*Haruka Maeda1, Isao Ito2,3, Konosuke Morimoto1, J-PAVE2 (1. Nagasaki University, 2. Gunma University, 3. Kyoto University)
[O5-04]Serotype Replacement and Clonal Dynamics Based on Nationwide Pediatric Pneumococcal Disease Surveillance (Pneumocatch Study), 2012–2023
*Yusuke Aoki1, Takao Fujisawa1, Mizuho Nagao2, Bin Chang3, Satoshi Nakano4, Masahiro Yamaguchi5, Yoshikazu Nakayama5, Adriano Arguedas-Mohs6, Claudia Schwarz6, Shigeru Suga1 (1. Department of Pediatrics, National Hospital Organization Mie Hospital, 2. Clinical Research Department, National Hospital Organization Mie Hospital, 3. Department of Bacteriology I, National Institute of Infectious Diseases, 4. Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, 5. Vaccine Medical Affairs, Medical Japan, Pfizer Japan Inc., 6. Collegeville, US, Pfizer Inc.)
[O5-05]COVID-19パンデミック期間中とパンデミック前後期の侵襲性肺炎球菌肺炎患者の比較と肺炎球菌ワクチン接種歴の検討
*Masafumi Seki1 (1. Department of Infectious Diseases and Infection Control, Saitama Medical University International Medical Center)